Anshuman Panda

1.4k total citations
24 papers, 844 citations indexed

About

Anshuman Panda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Anshuman Panda has authored 24 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Anshuman Panda's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (5 papers) and Ferroptosis and cancer prognosis (4 papers). Anshuman Panda is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (5 papers) and Ferroptosis and cancer prognosis (4 papers). Anshuman Panda collaborates with scholars based in United States, India and Netherlands. Anshuman Panda's co-authors include Shridar Ganesan, Gyan Bhanot, Mark N. Stein, Kathryn E. Beckermann, Aguirre A. de Cubas, W. Kimryn Rathmell, Benjamin G. Vincent, Jonathan S. Serody, Christof C. Smith and Janice M. Mehnert and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Anshuman Panda

23 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anshuman Panda United States	10	424	358	215	215	211	24	844
Jason Willis United States	12	357 0.8×	660 1.8×	81 0.4×	642 3.0×	88 0.4×	51	1.1k
Atsuko Katagiri Japan	17	205 0.5×	621 1.7×	58 0.3×	231 1.1×	96 0.5×	37	956
Aatish Thennavan United States	8	313 0.7×	327 0.9×	267 1.2×	200 0.9×	102 0.5×	21	691
John Stone United Kingdom	3	628 1.5×	427 1.2×	79 0.4×	110 0.5×	53 0.3×	5	780
Asha Konde United Kingdom	5	463 1.1×	545 1.5×	42 0.2×	97 0.5×	122 0.6×	8	716
Chandramohan S. Ishwad United States	14	158 0.4×	311 0.9×	25 0.1×	132 0.6×	68 0.3×	20	547
Douglas V.N.P. Oliveira Denmark	12	204 0.5×	508 1.4×	32 0.1×	179 0.8×	51 0.2×	26	697
Lisle E. Mose United States	12	292 0.7×	386 1.1×	152 0.7×	241 1.1×	112 0.5×	19	757
Deepti P. Wilks United Kingdom	8	149 0.4×	303 0.8×	25 0.1×	129 0.6×	76 0.4×	11	499

Countries citing papers authored by Anshuman Panda

Since Specialization

Citations

This map shows the geographic impact of Anshuman Panda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anshuman Panda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anshuman Panda more than expected).

Fields of papers citing papers by Anshuman Panda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anshuman Panda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anshuman Panda. The network helps show where Anshuman Panda may publish in the future.

Co-authorship network of co-authors of Anshuman Panda

This figure shows the co-authorship network connecting the top 25 collaborators of Anshuman Panda. A scholar is included among the top collaborators of Anshuman Panda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anshuman Panda. Anshuman Panda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Panda, Anshuman, et al.. (2022). A Gene Panel for Early Identification of Future Responders to Immune Checkpoint Blockade. Frontiers in Genetics. 13. 706468–706468. 2 indexed citations

Bajpai, Manisha, et al.. (2021). Recurring Translocations in Barrett’s Esophageal Adenocarcinoma. Frontiers in Genetics. 12. 674741–674741. 4 indexed citations

Panda, Anshuman, et al.. (2021). Barrett’s Epithelium to Esophageal Adenocarcinoma: Is There a “Point of No Return”?. Frontiers in Genetics. 12. 706706–706706. 3 indexed citations

Tong, Kevin, Anshuman Panda, Lanjing Zhang, et al.. (2021). SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis. Oncogene. 40(41). 6034–6048. 17 indexed citations

Panda, Anshuman & Shridar Ganesan. (2021). Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer. Frontiers in Genetics. 12. 706435–706435. 9 indexed citations

Panda, Anshuman, Gyan Bhanot, Shridar Ganesan, & Manisha Bajpai. (2021). Gene Expression in Barrett’s Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma. Cancers. 13(23). 5971–5971. 2 indexed citations

Panda, Anshuman, Anupama Yadav, Huwate Yeerna, et al.. (2020). Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples. Nucleic Acids Research. 48(13). 7079–7098. 19 indexed citations

Cubas, Aguirre A. de, William Dunker, Rachel A. Hongo, et al.. (2020). DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer. JCI Insight. 5(11). 46 indexed citations

Panigrahi, Ramakanta, et al.. (2020). Influence of GGBS on the Properties of Charge Chrome Based Geopolymer Concrete in Ambient Temperature. SSRN Electronic Journal. 2 indexed citations

10.

Panda, Anshuman, Mark N. Stein, Gregory Riedlinger, Gyan Bhanot, & Shridar Ganesan. (2019). Role for immune checkpoint blockade in BRCA2-mutant prostate cancer.. Journal of Clinical Oncology. 37(8_suppl). 59–59. 2 indexed citations

11.

Smith, Christof C., Kathryn E. Beckermann, Dante S. Bortone, et al.. (2018). Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. Journal of Clinical Investigation. 128(11). 4804–4820. 198 indexed citations

12.

Panda, Anshuman, Aguirre A. de Cubas, Mark N. Stein, et al.. (2018). Endogenous retrovirus expression is associated with response to immune checkpoint pathway in clear cell renal cell carcinoma. JCI Insight. 3(16). 118 indexed citations

13.

Panda, Anshuman, Gregory Riedlinger, Mark N. Stein, et al.. (2018). Expression of endogenous retroviruses and response to immune checkpoint therapy in renal cell cancer.. Journal of Clinical Oncology. 36(5_suppl). 104–104. 2 indexed citations

14.

Mohapatra, Subasish, et al.. (2018). A Modern Approach for Load Balancing Using Forest Optimization Algorithm. 85–90. 5 indexed citations

15.

Panda, Anshuman, Surendra Kumar, Michael Seiler, et al.. (2017). Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. Scientific Reports. 7(1). 5568–5568. 32 indexed citations

16.

Panda, Anshuman, Kalyanasundaram Subramanian, Jeffrey S. Ross, et al.. (2017). Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors. JCO Precision Oncology. 2017(1). 1–13. 50 indexed citations

17.

Verma, Yogesh Kumar, et al.. (2017). Free Dry Vibration of Low-Aspect-Ratio Cantilever Wing: SemiAnalytical and Numerical Analysis With Experimental Verification. Journal of Ship Production and Design. 33(3). 247–256. 1 indexed citations

18.

Yadav, Anupama, et al.. (2016). The Modular Adaptive Ribosome. PLoS ONE. 11(11). e0166021–e0166021. 8 indexed citations

19.

Mehnert, Janice M., Anshuman Panda, Judy Zhong, et al.. (2016). Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer. Journal of Clinical Investigation. 126(6). 2334–2340. 290 indexed citations

20.

Mehnert, Janice M., Anshuman Panda, H. Zhong, et al.. (2015). Abstract PR05: Exceptional Response to PD-1 antibody treatment in a POLE-mutant endometrial cancer. Molecular Cancer Therapeutics. 14(12_Supplement_2). PR05–PR05. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact